Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/23068
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Georgiou, Anastasios M. | - |
dc.date.accessioned | 2021-09-20T05:36:02Z | - |
dc.date.available | 2021-09-20T05:36:02Z | - |
dc.date.issued | 2015-03 | - |
dc.identifier.citation | International Journal of Health & Allied Sciences, vol. 4, no, 1, pp. 3-8 | en_US |
dc.identifier.issn | 2278344X | - |
dc.identifier.uri | https://hdl.handle.net/20.500.14279/23068 | - |
dc.description.abstract | At present, the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved drugs for Relapsing Remitting Multiple Sclerosis (RRMS) and Secondary Progressive MS (SPMS). In this paper, modern therapeutic strategies for MS are reviewed. A comprehensive research in MEDLINE, PUBMED, and SCIENCEDIRECT databases using two Boolean phrases {i.e. 1. [(Multiple Sclerosis) and (Disease Modifying Therapies)] and 2. [(Multiple Sclerosis) and (Neuroprotective Therapies)]} yielded more than 1,5000 articles in total. Therefore, for the purposes of this paper, articles written within the last decade were considered for review. | en_US |
dc.format | en_US | |
dc.language.iso | en | en_US |
dc.relation.ispartof | International Journal of Health & Allied Sciences | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Disease‑modifying therapies | en_US |
dc.subject | Multiple sclerosis | en_US |
dc.subject | Neuroprotective strategies | en_US |
dc.title | Therapeutic strategies for multiple sclerosis: Current data | en_US |
dc.type | Article | en_US |
dc.collaboration | James Cook University | en_US |
dc.subject.category | Clinical Medicine | en_US |
dc.journals | Open Access | en_US |
dc.country | Australia | en_US |
dc.subject.field | Medical and Health Sciences | en_US |
dc.publication | Peer Reviewed | en_US |
dc.identifier.doi | 10.4103/2278-344X.149199 | en_US |
dc.relation.issue | 1 | en_US |
dc.relation.volume | 4 | en_US |
cut.common.academicyear | 2014-2015 | en_US |
dc.identifier.spage | 3 | en_US |
dc.identifier.epage | 8 | en_US |
item.openairetype | article | - |
item.cerifentitytype | Publications | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Department of Rehabilitation Sciences | - |
crisitem.author.faculty | Faculty of Health Sciences | - |
crisitem.author.orcid | 0000-0001-8583-6760 | - |
crisitem.author.parentorg | Faculty of Health Sciences | - |
crisitem.journal.journalissn | 2278-344X | - |
crisitem.journal.publisher | Kluwer | - |
Appears in Collections: | Άρθρα/Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IntJHealthAlliedSci413-1951091_052510.pdf | Fulltext | 558.31 kB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
279
Last Week
1
1
Last month
2
2
checked on Jan 28, 2025
Download(s)
214
checked on Jan 28, 2025
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License